SHANGHAI and SAN FRANCISCO, May 27, 2020 (GLOBE NEWSWIRE) — Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced that the Company will be presenting at the following upcoming virtual conferences in June. Details of the virtual conferences are as follows:
Jefferies Global Healthcare Conference 2020
Presentation: Tuesday, June 2, 2020 at 3:00 p.m. EDT
Presenter: Dr. Samantha Du, Founder, Chairperson & Chief Executive OfficerGoldman Sachs 41st Annual Global Healthcare Conference
Presentation: Thursday, June 11, 2020 at 9:40 a.m. EDT
Presenter: Dr. Samantha Du, Founder, Chairperson & Chief Executive OfficerJP Morgan China Investor Conference
Panel Discussion: Wednesday, June 24, 2020 at 8:00 a.m. CST
Presenter: Dr. Samantha Du, Founder, Chairperson & Chief Executive OfficerLive webcasts of the conferences will be available under “Events & Presentations” in the “Investors Relations” section of Zai Lab’s website. Archived replays will be available for 90 days following the event.About Zai LabZai Lab (NASDAQ:ZLAB) is an innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China’s pharmaceutical market and address unmet medical needs, Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates. Zai Lab has also built an in-house team with strong drug discovery and translational research capabilities, aiming to establish a global pipeline of proprietary drug candidates against targets in our focus areas. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide.For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.For more information, please contact:ZAI LAB CONTACTS:Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.comMedia: Ryo Imai / Robert Flamm, Ph.D.
Burns McClellan, on behalf of Zai Lab
212-213-0006 ext. 315 / 364
rimai@burnsmc.com / rflamm@burnsmc.comInvestors: Pete Rahmer / Mike Zanoni
Endurance Advisors, on behalf of Zai Lab
415-515-9763 / 610-442-8570
prahmer@enduranceadvisors.com / mzanoni@enduranceadvisors.com
Bay Street News